COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 436: Articles 4351-4360  | Next

Defining drivers of under-immunisation and vaccine hesitancy in refugee and migrant populations globally to support strategies to strengthen vaccine uptake for COVID-19: a rapid review
Deal, A., Crawshaw, A. F., Carter, J., Knights, F., Iwami, M., Darwish, M., Hossain, R., Immordino, P., Kaojaroen, K., Severoni, S., Hargreaves, S.
10.1101/2023.03.20.23287477 — Posted: 2023-03-20
Antibiotic prescribing in remote versus face-to-face consultations for acute respiratory infections in English primary care: An observational study using TMLE
Vestesson, E., De Corte, K. L. A., Chappell, P., Crellin, E., Clarke, G. M.
10.1101/2023.03.20.23287466 — Posted: 2023-03-20
New Approach to the SIR Inversion Problem: From the 1905-1906 Plague Outbreak in the Isle of Bombay to the 2021-2022 Omicron Surges in New York City and Los Angeles County
Harris, J. E.
10.1101/2023.03.13.23287177 — Posted: 2023-03-20
Childhood Adversity and COVID-19 Outcomes: Findings from the UK Biobank
Hanson, J. L., O'Connor, K. A., Adkins, D. J., Kahhale, I.
10.1101/2023.03.20.23287479 — Posted: 2023-03-20
Safety and Effectiveness of SA58 Nasal Spray against SARS-CoV-2 family transmission: an exploratory single-arm trial
Wang, L., Song, R., Hu, Y., Zeng, G., Sun, K., Wang, J., Bao, Y., Zhou, Y., Cheng, L., Wu, C., Pu, J., Han, X., Wu, J., Jin, R., Gao, Q.
10.1101/2023.03.19.23287462 — Posted: 2023-03-20
Data-driven control of airborne infection risk and energy use in buildings
Risbeck, M. J., Cohen, A. E., Douglas, J. D., Jiang, Z., Fanone, C. M., Bowes, K., Doughty, J., Turnbull, M., DiBerardinis, L., Lee, Y. M., Bazant, M. Z.
10.1101/2023.03.19.23287460 — Posted: 2023-03-20
Analysis of spike protein variants evolved in a novel mouse model of persistent SARS-CoV-2 infection
Kim, D., Kim, J., Kim, M., Park, H., Maharjan, S., Baek, K., Kang, B. M., Kim, S., Park, S., Park, M.-S., Lee, Y., Kwon, H.-J.
10.1101/2023.03.19.533317 — Posted: 2023-03-20
SARS-CoV-2 NSP12 associates with the TRiC complex and the P323L substitution is a host adaption.
Alruwaili, M., Armstrong, S., Prince, T., Erdmann, M., Davidson, A. D., Matthews, D. A., AlJabr, W., Hiscox, J. A.
10.1101/2023.03.18.533280 — Posted: 2023-03-20
Coronavirus endoribonuclease nsp15 induces host cellular protein synthesis shutoff
Liao, Y., Gong, X., Feng, S., Gao, B., Fang, S., Weng, W., Chu, H., Yuan, Y., Cheng, Y., Sun, Y., Tan, L., Song, C., Qiu, X., Ding, C., Liao, M., Tijhaar, E., Forlenza, M.
10.1101/2023.03.20.533404 — Posted: 2023-03-20
Mouse Adapted SARS-CoV-2 Model Induces "Long-COVID" Neuropathology in BALB/c Mice
Gressett, T. E., Leist, S. R., Ismael, S., Talkington, G., Dinnon, K. H., Baric, R. S., Bix, G.
10.1101/2023.03.18.533204 — Posted: 2023-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).